ClinicalTrials.Veeva

Menu

Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer

B

Bnai Zion Medical Center

Status

Enrolling

Conditions

Cancer

Treatments

Other: Chemotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05599698
0106-22-BNZ

Details and patient eligibility

About

The purpose of this study is to examine changes in perceived daily performance and executive functioning following chemotherapy in individuals with non-central nervous system cancers.

Enrollment

38 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newly diagnosed with a primary non-central nervous system malignancy (lung, breast, colon, ulcer, urinary tract, canine tumors).
  • Stages I-III.
  • Pre-commencement of adjuvant (post-surgery) or neoadjuvant (prior to surgery) chemotherapy.
  • Understand and read Hebrew.
  • Have at least 12 years of education.

Exclusion criteria

  • Diagnosed with central nervous system malignancies.
  • Had a previous malignancy.
  • Have or had metastatic disease.
  • Have a history of a neurological condition or severe depression.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

38 participants in 1 patient group

chemotherapy
Experimental group
Description:
chemotherapy
Treatment:
Other: Chemotherapy

Trial contacts and locations

1

Loading...

Central trial contact

khawla loubani, PhD; Abed Agbarya, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems